James Brady's Insider Trades & SAST Disclosures

James Brady's most recent trade in Xeris Biopharma Holdings Inc was a trade of 100,000 Common Stock done . Disclosure was reported to the exchange on March 28, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Xeris Biopharma Holdings Inc
James Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 100,000 100,000 (0%) 0% 0 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. 31 May 2024 2,826 297,227 (0%) 0% 15.5 43,944 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. 31 May 2024 2,629 300,053 (0%) 0% 15.6 40,881 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.94 per share. 23 May 2024 13,936 310,606 (0%) 0% 15.9 222,140 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.94 per share. 23 May 2024 7,924 302,682 (0%) 0% 15.9 126,309 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2024 68,864 324,542 (0%) 0% 0 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 35,427 255,678 (0%) 0% 0 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.21 per share. 28 Mar 2024 4,935 220,251 (0%) 0% 21.2 104,671 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.73 per share. 14 Jul 2023 8,962 225,186 (0%) 0% 27.7 248,516 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.03 per share. 31 May 2023 17,283 239,538 (0%) 0% 25.0 432,593 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.03 per share. 31 May 2023 2,792 236,746 (0%) 0% 25.0 69,884 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.79 per share. 31 May 2023 2,598 234,148 (0%) 0% 24.8 64,404 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 56,795 256,821 (0%) 0% 0 Common Stock
DXC Technology Co
James Michael Brady EVP, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2023 41,796 200,026 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades